| Title |
Author |
Type |
Date |
Words |
| Genzyme Reports Positive Top-Line Results of TOWER, a Pivotal Phase III Trial for AUBAGIOTM* (teriflunomide) in Relapsing Multiple Sclerosis. |
|
|
Jun 1, 2012 |
1416 |
| GE Healthcare Licenses Genomic Biomarker for Lung Cancer from Insight Genetics. |
|
|
May 31, 2012 |
1095 |
| Affymetrix and Leica Microsystems Announce Worldwide Collaboration on Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay for Research Use. |
|
|
May 31, 2012 |
875 |
| New Promega Luciferase is Smaller, Brighter, and More Versatile. |
|
|
May 31, 2012 |
435 |
| Insight Genetics and Kindstar Global Partner to Enhance Cancer Care in China. |
|
|
May 31, 2012 |
924 |
| Spectrum Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference. |
|
Conference news |
May 31, 2012 |
645 |
| Hepatitis B Foundation Honors U.S. Assistant Secretary for Health Dr. Howard Koh and Breaks Fundraising Record at Crystal Ball. |
|
|
May 31, 2012 |
661 |
| A New Facility for the 10-Year Anniversary of GenScript. |
|
|
May 31, 2012 |
297 |
| Molecular Partners AG strengthens management team with the appointment of Lisa Rojkjaer, MD as Chief Medical Officer. |
|
|
May 31, 2012 |
721 |
| Catabasis Pharmaceuticals Appoints Henry Rath to Vice President, Business Development. |
|
|
May 31, 2012 |
480 |
| ArQule, Inc. to Present at Jefferies 2012 Global Healthcare Conferences. |
|
Conference news |
May 31, 2012 |
232 |
| Seattle Genetics to Present at Upcoming Investor Conferences. |
|
Conference news |
May 31, 2012 |
307 |
| Oncolytics Biotech[R] Inc. Signs Sponsorship Pact with NCIC CTG. |
|
Clinical report |
May 31, 2012 |
379 |
| VWR International, LLC to Acquire basan Germany GmbH. |
|
|
May 31, 2012 |
320 |
| 2012 BIO International Convention Buzz of BIO Winner Announced. |
|
|
May 30, 2012 |
798 |
| A New Facility for the 10-Year Anniversary of GenScript. |
|
|
May 30, 2012 |
303 |
| Morphotek Earns Prestigious Award For Innovation In Assay Development. |
|
Clinical report |
May 30, 2012 |
691 |
| Cannabis Science Creates "Cannabis Science Research Foundation" and Looks Forward to Inaugural Event in the Near Future. |
|
|
May 30, 2012 |
821 |
| Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis. |
|
|
May 30, 2012 |
537 |
| Bioenergy Life Science, Inc. Posts Record Growth in First Six Months After Joining Top Chinese Biotech Company. |
|
Company overview |
May 30, 2012 |
577 |
| Exelixis Initiates COMET-1 Pivotal Trial Focused on Overall Survival in Men With Advanced Prostate Cancer. |
|
|
May 30, 2012 |
1478 |
| Amarantus BioSciences President & CEO Gerald Commissiong, talks live with 'The Stock Radio' from Wall Street 1-2-1 event in Orlando, Florida. |
|
|
May 30, 2012 |
657 |
| PROLOR Biotech to Present at Jefferies 2012 Global Health Care Conference. |
|
Conference news |
May 30, 2012 |
495 |
| Puma Biotechnology to Present at Jefferies Healthcare Conference. |
|
Conference news |
May 30, 2012 |
348 |
| Response Genetics Announces Presentation of Lung Cancer Study Results at 2012 American Society of Clinical Oncology Annual Meeting. |
|
Clinical report |
May 30, 2012 |
1187 |
| Genzyme Recognizes World MS Day. |
|
|
May 30, 2012 |
806 |
| Prolacta Bioscience Makes Additional Donation to Make-A-Wish[R]. |
|
|
May 30, 2012 |
762 |
| Amgen Canada Heralded as Leader in Communities from Coast to Coast. |
|
|
May 30, 2012 |
385 |
| Neurometabolic Disorders Market to 2017 - Novel Therapies for Rare Diseases such as Gaucher's and Niemann-Pick Poised to Supersede Existing Therapies. |
|
|
May 30, 2012 |
4261 |
| Illumina to Webcast Live Presentations at Upcoming Investment Conferences in June. |
|
Conference news |
May 30, 2012 |
294 |
| Alnylam Announces Top-Line Results of Phase IIb Clinical Trial of ALN-RSV01, an Inhaled RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection. |
|
|
May 30, 2012 |
3361 |
| Exelixis Completes Submission of New Drug Application for Cabozantinib for the Treatment of Medullary Thyroid Cancer. |
|
|
May 30, 2012 |
851 |
| Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis. |
|
|
May 30, 2012 |
530 |
| Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc. |
|
|
May 29, 2012 |
1575 |
| Ensemble Therapeutics and Genentech Initiate Collaboration to Discover Macrocyclic Drug Candidates. |
|
|
May 29, 2012 |
666 |
| Sequenom Announces Participation at the Jefferies Global Healthcare Conference. |
|
Conference news |
May 29, 2012 |
331 |
| Genzyme and Isis Announce Filing of U.S. NDA for KYNAMRO[TM] (mipomersen sodium) in Homozygous Familial Hypercholesterolemia. |
|
|
May 29, 2012 |
1812 |
| Advaxis Completes Enrollment in Phase 2 Cervical Cancer Study. |
|
Report |
May 29, 2012 |
791 |
| Academic and Tech Transfer Community to be Spotlighted at the 2012 BIO International Convention. |
|
|
May 29, 2012 |
1093 |
| Elan to Present at Jefferies 2012 Global Healthcare Conference. |
|
Conference news |
May 28, 2012 |
173 |
| Janine S. (Marks) Profenno, 62. |
|
|
May 27, 2012 |
147 |
| Jeffrey R. Harder Joins Jackson Walker. |
|
|
May 27, 2012 |
226 |
| ImmunoReagents Signs Chinese Distributorship Agreement with AmyJet Scientific. |
|
|
May 27, 2012 |
337 |
| ImmunoCellular Therapeutics Receives Approval for NYSE MKT Listing. |
|
|
May 25, 2012 |
322 |
| Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc. |
|
|
May 25, 2012 |
1563 |
| BIO Applauds EPA's Rejection of a Petition to Retroactively Waive the 2011 Renewable Fuel Standard. |
|
|
May 25, 2012 |
616 |
| BIO Statement on New Bill to Extend Therapeutic Discovery Project Tax Credit. |
|
|
May 24, 2012 |
742 |
| BIO Lauds Senate Passage of User Fee Package. |
|
|
May 24, 2012 |
725 |
| Aviir Diagnostics Laboratory In Collaboration With Cause;ology Sponsors "Purses from the Heart" Charity Event At The SLS Hotel In Beverly Hills. |
|
|
May 24, 2012 |
732 |
| Ludhiana- based firms' dengue antidote caught in red tape despite clearing trials. |
|
|
May 24, 2012 |
147 |
| Boston CEO Conference to Feature CEOs of Alkermes, Alnylam, Ariad, Biogen, Cubist, Genzyme, Millennium, Momenta, Sirtris, and Others June 11th and 12th. |
|
Conference news |
May 24, 2012 |
257 |
| Transgenomic Acquires Clinical Sample Biorepository from Gene Logic. |
|
|
May 24, 2012 |
605 |
| Thermo Fisher Scientific Declares Quarterly Dividend. |
|
|
May 24, 2012 |
213 |
| Cellectricon Launches Cellaxess Elektra Discovery Platform. |
|
|
May 24, 2012 |
397 |
| Joint Venture Opportunities; PITTSBURGH LIFE SCIENCES GREENHOUSE. |
|
|
May 24, 2012 |
105 |
| Joint Venture Opportunities; MASSACHUSETTS BIOMEDICAL INITIATIVES. |
|
|
May 24, 2012 |
107 |
| Cold Spring Harbor Laboratory Joins the Illumina Genome Network. |
|
|
May 23, 2012 |
517 |
| MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan. |
|
|
May 23, 2012 |
977 |
| MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan. |
|
|
May 23, 2012 |
987 |
| Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent. |
|
|
May 23, 2012 |
1456 |
| Seattle Genetics Announces Health Canada Accepts ADCETRIS[R] New Drug Submission for Review. |
|
|
May 23, 2012 |
824 |
| BiovaxID[R] Personalized Lymphoma Vaccine is Featured in Article Published in Scrip Intelligence. |
|
|
May 22, 2012 |
888 |
| Bench International Acquires TRIOS Search Partners. |
|
|
May 22, 2012 |
423 |
| Mirna Therapeutics Presents Updates on Development Program for Lead Therapeutic Candidate. |
|
|
May 22, 2012 |
707 |
| Diamyd Medical's Phase II study in cancer pain fully recruited. |
|
|
May 22, 2012 |
1039 |
| Deltagen Reports 2012 First Quarter Financial Results. |
|
Financial report |
May 22, 2012 |
4610 |
| GeneLink Reports First Quarter 2012 Financial Results. |
|
Financial report |
May 22, 2012 |
484 |
| Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation. |
|
|
May 22, 2012 |
429 |
| IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research. |
|
|
May 22, 2012 |
827 |
| Joint Venture Opportunities; PITTSBURGH LIFE SCIENCES GREENHOUSE. |
|
|
May 21, 2012 |
105 |
| Joint Venture Opportunities; MASSACHUSETTS BIOMEDICAL INITIATIVES. |
|
|
May 21, 2012 |
107 |
| THE BIOTECH GROWTH TRUST PLC - Transaction in Own Shares. |
|
|
May 21, 2012 |
276 |
| 600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical Phase III Study. |
|
Clinical report |
May 21, 2012 |
1490 |
| Pacira Pharmaceuticals, Inc. to Be Added to NASDAQ Biotechnology Index. |
|
|
May 21, 2012 |
293 |
| Sangamo BioSciences And Collaborators Highlight Widening Applications Of ZFP Therapeutics In Presentations At Major Gene Therapy Meeting. |
|
|
May 21, 2012 |
1055 |
| Eureka Genomics Awarded Multi Year Contract to Assist Military Laboratory With DNA Sequencing. |
|
|
May 21, 2012 |
297 |
| VBL Therapeutics Presents Positive Preclinical Data for VB-201 in Inflammatory Bowel Disease at Digestive Disease Week (DDW) 2012. |
|
|
May 21, 2012 |
760 |
| Transgenomic Announces CE IVD Mark for the WAVE MCE System and SURVEYOR[R] Scan KRAS Kit in Europe. |
|
|
May 21, 2012 |
1286 |
| Pressure BioSciences, LEAP Technologies, Sage-N Research, and Valco Instruments Announce Plans to Co-Develop Next Generation Sample Preparation/Data Analysis Platform for H/D Exchange Mass Spectrometry. |
|
|
May 21, 2012 |
1635 |
| High School Students Named Winners in Local Biotechnology Research Competition. |
|
|
May 21, 2012 |
685 |
| THE BIOTECH GROWTH TRUST PLC - Monthly Fact Sheet as at 30 April 2012. |
|
|
May 21, 2012 |
130 |
| Active Biotech and Ipsen to Present Tasquinimod Phase II Overall Survival Data at the 2012 ASCO Annual Meeting. |
|
Conference news |
May 18, 2012 |
1344 |
| Cardio3 BioSciences Has Been Selected to Present C3BS-CQR-1 Trial Data in Late Breaking Clinical Trial Session at European Society of Cardiology 2012 Heart Failure Congress. |
|
|
May 18, 2012 |
697 |
| Arqule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib in Non-small Cell Lung Cancer. |
|
|
May 18, 2012 |
1431 |
| Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21(TM) PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets. |
|
Clinical report |
May 18, 2012 |
1334 |
| ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib in Non-Small Cell Lung Cancer. |
|
|
May 18, 2012 |
1338 |
| New York Biotechnology Association to Honor Regeneron Founders as Business Leaders of the Year. |
|
|
May 18, 2012 |
454 |
| Advanced Cell Technology to Present at World Stem Cells & Regenerative Medicine Congress in London. |
|
|
May 18, 2012 |
762 |
| Globe 100 Annual List to Feature 100 Companies for First Time since 2009, Illustrating Resurgence of the Massachusetts Economy. |
|
Directory |
May 18, 2012 |
797 |
| Cannabis Science Supports Judge Gustin L. Reichbach's 'Plea for Pot' in New York Times Op-Ed for his Pancreatic Cancer. |
|
|
May 18, 2012 |
981 |
| Syngenta, Dow AgroSciences to Offer Reduced Structured Refuge Stacked Trait Options to Independent Seed Companies. |
|
|
May 17, 2012 |
816 |
| Joint Venture Opportunities; PITTSBURGH LIFE SCIENCES GREENHOUSE. |
|
|
May 17, 2012 |
105 |
| Joint Venture Opportunities; MASSACHUSETTS BIOMEDICAL INITIATIVES. |
|
|
May 17, 2012 |
107 |
| Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine. |
|
|
May 17, 2012 |
1204 |
| Human Genome Sciences Announces Adoption of Short-Term Stockholder Rights Plan. |
|
|
May 17, 2012 |
1184 |
| Positive Phase 2 Clinical Data With Tivantinib in Hepatocellular Carcinoma to be Highlighted in Oral Presentation at 2012 Annual Meeting of American Society of Clinical Oncology. |
|
|
May 17, 2012 |
1505 |
| Egalet to Present at Life Sciences Europe Conference. |
|
Conference news |
May 17, 2012 |
353 |
| Ceregene Parkinson's Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin). |
|
|
May 17, 2012 |
1189 |
| Egalet to Present at Life Sciences Europe Conference. |
|
Conference news |
May 17, 2012 |
358 |
| Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting. |
|
|
May 17, 2012 |
393 |
| Positive Phase 2 Clinical Data with Tivantinib in Hepatocellular Carcinoma to Be Highlighted in Oral Presentation at 2012 Annual Meeting of American Society of Clinical Oncology. |
|
Clinical report |
May 17, 2012 |
1492 |
| Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for Circulating Tumor Cell (CTC) Technology. |
|
|
May 17, 2012 |
904 |
| ImmunoGen, Inc. Announces Presentations at 2012 ASCO Annual Meeting on Product Candidates with the Company's TAP Technology. |
|
|
May 16, 2012 |
805 |
| Reminder: Exelixis Announces Data Presentations, Webcast of Investor Briefing in Conjunction With 2012 ASCO Annual Meeting. |
|
|
May 16, 2012 |
1175 |
| Pulmatrix Announces Presentations at ATS 2012 International Conference. |
|
Conference news |
May 16, 2012 |
628 |
| Verdezyne Names Ray W. Miller as Chief Business Officer. |
|
|
May 16, 2012 |
433 |
| Cerebain Biotech Corp. Signs Agreement with Medical Device Product Development Company. |
|
|
May 16, 2012 |
560 |
| NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic(TM) Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels. |
|
|
May 16, 2012 |
901 |
| Global Biotechnology Instrumentation Industry. |
|
|
May 16, 2012 |
5239 |
| CytoDyn Announces Plans to Move Forward with Next Stage of Research of CytoFeline[TM]. |
|
|
May 16, 2012 |
1008 |
| Panel of Top Industry Executives to Discuss Biotech and Big Pharma - What's Next? - 2012 BIO International Convention Keynote. |
|
|
May 16, 2012 |
821 |
| Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012. |
|
|
May 16, 2012 |
3837 |
| Seattle Genetics to Present ADCETRIS[R] and ASG-5ME Data at ASCO Annual Meeting. |
|
|
May 16, 2012 |
760 |
| Global Nanobiotechnology Industry. |
|
|
May 16, 2012 |
4497 |
| Global Biochips Industry. |
|
|
May 16, 2012 |
5021 |
| Global Bioinformatics Industry. |
|
|
May 16, 2012 |
4876 |
| New Study Shows Adaptive Biotechnologies immunoSEQ Assay Significantly More Sensitive than Traditional Method to Detect Minimal Residual Disease in Leukemia. |
|
|
May 16, 2012 |
886 |
| Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update. |
|
Financial report |
May 15, 2012 |
330 |
| Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers. |
|
|
May 15, 2012 |
1244 |
| GeoVax Labs Reports 2012 First Quarter Financial Results. |
|
Financial report |
May 15, 2012 |
3485 |
| Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion. |
|
|
May 15, 2012 |
1537 |
| Sinovac Reports Unaudited First Quarter 2012 Financial Results. |
|
Financial report |
May 15, 2012 |
10664 |
| Scil Proteins Enters Drug Discovery Collaboration with Ono for Affilin[R] Therapeutics. |
|
|
May 15, 2012 |
731 |
| Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical Sales and Marketing. |
|
|
May 15, 2012 |
648 |
| Infinity Added to NASDAQ Biotechnology Index. |
|
|
May 15, 2012 |
710 |
| Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of Antibiotics and Antibodies. |
|
|
May 15, 2012 |
1198 |
| ACADIA Pharmaceuticals to Webcast Educational Program on Parkinson's Disease Psychosis on May 22, 2012. |
|
|
May 15, 2012 |
745 |
| Advaxis Retires $4.5 Million in Debt, Adds $1,240,000 in New Financing. |
|
|
May 15, 2012 |
1102 |
| Celldex Therapeutics Added to Nasdaq Biotechnology Index. |
|
|
May 15, 2012 |
701 |
| Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer. |
|
|
May 15, 2012 |
765 |
| Array BioPharma and Genentech's Strategic Alliance Voted Breakthrough Alliance of 2012. |
|
|
May 14, 2012 |
883 |
| Orexigen Therapeutics To Be Added to the NASDAQ Biotechnology Index. |
|
|
May 14, 2012 |
351 |
| SILENCE THERAPEUTICS PLC - Publication of 2011 Annual Report and Notice of AGM. |
|
|
May 14, 2012 |
570 |
| Cellerant Announces Publication Demonstrating Significant Survival Benefits and Preclinical Proof of Concept With Myeloid Progenitors as Radiation Countermeasure. |
|
|
May 14, 2012 |
911 |
| Maxygen to Receive $30 Million Payment from Bayer. |
|
|
May 14, 2012 |
685 |
| NEPIC service strength outstrips the UK as a whole. |
|
|
May 14, 2012 |
446 |
| Late-Stage Drugs Are Hotbed for Co-Development and Licensing Deals. |
|
|
May 14, 2012 |
426 |
| Helicos BioSciences Corporation Settles its Patent Litigation Against Pacific Biosciences, Inc. |
|
|
May 14, 2012 |
471 |
| Sinovac Names Danny Chung Chief Financial Officer. |
|
|
May 14, 2012 |
562 |
| Solazyme to Present at Investor Conferences. |
|
Conference news |
May 14, 2012 |
339 |
| Seattle Genetics to Present at Bank of America Merrill Lynch Health Care Conference. |
|
Conference news |
May 11, 2012 |
216 |
| Affymetrix to Webcast Annual Meeting of Shareholders. |
|
|
May 11, 2012 |
325 |
| Vetter Boosts Quality and Logistic Processes. |
|
Company overview |
May 11, 2012 |
675 |
| BUSINESS BRIEFS. |
|
|
May 11, 2012 |
453 |
| GeneLink Reports 2011 Financial Results. |
|
Financial report |
May 10, 2012 |
822 |
| Joint Venture Opportunities; PITTSBURGH LIFE SCIENCES GREENHOUSE. |
|
|
May 10, 2012 |
105 |
| Joint Venture Opportunities; MASSACHUSETTS BIOMEDICAL INITIATIVES. |
|
|
May 10, 2012 |
107 |
| Alnylam Presents Final Results from a Phase I Clinical Trial of ALN-TTR01, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of Transthyretin-Mediated Amyloidosis (ATTR). |
|
|
May 10, 2012 |
2387 |
| Eppendorf to Support BioNexus Companies in Malaysia. |
|
|
May 10, 2012 |
240 |
| Response Genetics, Inc. Announces First Quarter Financial Results. |
|
Financial report |
May 10, 2012 |
5795 |
| Seattle Genetics Announces Data from Investigator Trial of ADCETRIS[TM] in Relapsed Cutaneous T-Cell Lymphoma. |
|
|
May 10, 2012 |
1784 |
| Interleukin Genetics Reports First Quarter 2012 Financial Results. |
|
|
May 10, 2012 |
3043 |
| Exelixis Announces May 17th Webcast of Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference. |
|
Conference news |
May 10, 2012 |
268 |
| BUSINESS BRIEFS. |
|
|
May 10, 2012 |
384 |
| Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments. |
|
|
May 10, 2012 |
3359 |
| Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases% Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation. |
|
|
May 10, 2012 |
3198 |
| Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules. |
|
|
May 10, 2012 |
3163 |
| Coats and Bennett's Letao Qin, Ph.D., is Featured Guest at China Bioscience Connect Conference. |
|
|
May 9, 2012 |
464 |
| Puma Biotechnology to Present at BofA Merrill Lynch Health Care Conference. |
|
Conference news |
May 9, 2012 |
366 |
| ImmunoCellular Provides an Update on Enrollment for the Company's Phase II Clinical Trial. |
|
|
May 9, 2012 |
687 |
| Profectus BioSciences, Inc. Receives $5.6M Grant to Develop a Vaccine to Protect Humans against Infection with Nipah/Hendra Viruses. |
|
|
May 9, 2012 |
1094 |
| CPRIT Awards Pulmotect $7.1 Million to Develop Novel Immune System Stimulant. |
|
|
May 9, 2012 |
626 |
| Human Genome Sciences Board of Directors to Review Unsolicited Tender Offer From GlaxoSmithKline. |
|
|
May 9, 2012 |
925 |
| 2012 BIO International Convention to Highlight the FDA and Regulatory Environment. |
|
|
May 9, 2012 |
1341 |
| Alnylam to Webcast Presentation at Upcoming Investor Conferences. |
|
Conference news |
May 9, 2012 |
498 |
| Relationship Marketing Inc. Relaunches as RMi, Specialists In Biotech and Pharma. |
|
|
May 9, 2012 |
565 |
| Cardio3 BioSciences Announces CE Marking for its C-Cath Injection Catheter. |
|
|
May 9, 2012 |
803 |
| Amarantus BioSciences to Present at the Wall Street 1-2-1 Conference. |
|
Conference news |
May 9, 2012 |
964 |
| The Lupus Foundation of America Honors Leaders From Government and Industry at the 2012 National Butterfly Gala. |
|
|
May 9, 2012 |
936 |
| Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results. |
|
|
May 8, 2012 |
583 |
| University of Washington, University of Texas Medical Branch and Kineta, Inc. Granted $8.1 Million for Biodefense Antiviral Drug Development. |
|
|
May 8, 2012 |
1293 |
| ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. |
|
Conference news |
May 8, 2012 |
297 |
| Advaxis Announces Cancer Research UK Initiates Phase 1/2 Clinical Trial of ADXS-HPV for the Treatment of Head and Neck Cancer. |
|
|
May 8, 2012 |
998 |
| Spectrum Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference. |
|
Conference news |
May 8, 2012 |
663 |
| ChanTest Sponsors Great Strides Walk for Cystic Fibrosis. |
|
|
May 8, 2012 |
559 |
| ImmunoCellular Therapeutics CEO to Speak at Phacilitate Immunotherapy Leaders' Forum 2012. |
|
|
May 8, 2012 |
285 |
| Nuvilex Announces Excitement Grows in Japan over Encapsulated Living Cell Technology Oncological Applications. |
|
|
May 8, 2012 |
474 |
| Reminder: Transgenomic to Hold First Quarter Financial Results Conference Call Today. |
|
|
May 8, 2012 |
518 |
| Transgenomic Reports First Quarter 2012 Financial Results. |
|
Financial report |
May 8, 2012 |
6352 |
| Seattle Genetics Reports First Quarter 2012 Financial Results. |
|
Financial report |
May 8, 2012 |
4060 |
| Advanced Cell Technology Announces 2012 First Quarter Results. |
|
Financial report |
May 8, 2012 |
770 |
| Retrophin, LLC Completes Series A Financing. |
|
|
May 7, 2012 |
284 |
| Millennium and Seattle Genetics Initiate Global Phase 3 Trial of ADCETRIS[TM] in Patients with CD30-Expressing Relapsed Cutaneous T-cell Lymphoma. |
|
|
May 7, 2012 |
1836 |
| Advanced Cell Technology to Host Conference Call to Discuss 2012 First Quarter Results and Provide Corporate Update on Wednesday, May 9th. |
|
|
May 7, 2012 |
488 |
| Promedior Announces Presentation of Preclinical Data at ARVO Demonstrating that Pentraxin-2 Suppressed Fibrosis, Neovascularization, and Vascular Leakage. |
|
|
May 7, 2012 |
781 |
| "OneMedForum NY2012" To Feature Expert Panels, Investor Guides and Disruptive Technologies from Emerging Companies. |
|
|
May 7, 2012 |
583 |
| Maxygen Reports First Quarter 2012 Financial Results. |
|
Financial report |
May 7, 2012 |
3391 |
| Solazyme Reports First Quarter 2012 Results. |
|
Financial report |
May 7, 2012 |
5753 |
| Verenium To Present At The Deutsche Bank 2012 Clean Tech, Utilities & Power Conference. |
|
Conference news |
May 7, 2012 |
530 |
| Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates. |
|
|
May 7, 2012 |
593 |
| Pressure BioSciences, Inc. and LEAP Technologies, Inc. Announce Co-Development, Co-Marketing, & Co-Selling Agreement. |
|
|
May 7, 2012 |
1541 |
| Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates. |
|
|
May 7, 2012 |
595 |
| Sequenom Announces Participation at the Bank of America Merrill Lynch Health Care Conference. |
|
Conference news |
May 7, 2012 |
337 |
| Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic. |
|
|
May 7, 2012 |
531 |
| Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences. |
|
Conference news |
May 7, 2012 |
429 |
| Response Genetics, Inc. to Release First Quarter Financial Results and Host Conference Call on May 10, 2012. |
|
|
May 4, 2012 |
679 |
| NIRI San Diego May Meeting: Seasoned IROs Discuss "Tips & Tactics for Establishing and Maintaining A Successful Investor Relations Program". |
|
|
May 4, 2012 |
713 |
| Affymetrix and eBioscience Amend Definitive Merger Agreement. |
|
|
May 4, 2012 |
1189 |
| BUSINESS BRIEFS. |
|
|
May 3, 2012 |
353 |
| Joint Venture Opportunities; PITTSBURGH LIFE SCIENCES GREENHOUSE. |
|
|
May 3, 2012 |
105 |
| Joint Venture Opportunities; MASSACHUSETTS BIOMEDICAL INITIATIVES. |
|
|
May 3, 2012 |
107 |
| Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd. |
|
|
May 3, 2012 |
646 |
| Genzyme Announces Regulatory Approvals of Expanded Waterford, Ireland Manufacturing Plant. |
|
|
May 3, 2012 |
777 |
| Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection. |
|
|
May 3, 2012 |
1010 |
| Research and Markets: Genetics, 6th Edition International Student Version Continues To Educate Today's Students for Tomorrow's Science. |
|
|
May 3, 2012 |
389 |
| ArQule Reports First Quarter 2012 Financial Results. |
|
|
May 3, 2012 |
4195 |
| Exelixis Expands the Cabozantinib Development Program Through NCI-CTEP Collaboration. |
|
|
May 3, 2012 |
1492 |
| Cannabis Science Teams with Dr. Ivan Goldsmith of Trimcare in Las Vegas for Innovative Weight Loss Programs Based on Research of the Endocannabinoid System. |
|
|
May 3, 2012 |
654 |
| Alnylam Pharmaceuticals Reports First Quarter 2012 Financial Results. |
|
Financial report |
May 3, 2012 |
6449 |
| Lantheus Medical Imaging Announces Appointment of Alexander E. Kuta, Ph.D., as Vice President, Global Regulatory Affairs and Nigel Williams as Vice President, Quality. |
|
|
May 3, 2012 |
701 |
| Affymetrix Reports First Quarter 2012 Results. |
|
Financial report |
May 3, 2012 |
6175 |
| Exelixis Announces First Quarter 2012 Financial Results. |
|
Financial report |
May 3, 2012 |
5711 |
| ADMA Biologics Appoints Brian Lenz as Chief Financial Officer. |
|
|
May 3, 2012 |
568 |
| RBCC Target Amarantus BioSciences Reports Positive Pre-Clinical Results of Parkinson's Treatment. |
|
Financial report |
May 2, 2012 |
667 |
| Advaxis Announces Abstracts Accepted for Poster Presentation at ASCO Annual Meeting 2012. |
|
|
May 2, 2012 |
770 |
| Illumina to Webcast Live Presentations at Upcoming Investment Conferences in May. |
|
Conference news |
May 2, 2012 |
289 |
| I'm taking my cause back to London... Dad's campaign over son. |
|
|
May 2, 2012 |
418 |
| Eureka Genomics Launches a Novel Custom Genotyping Service. |
|
|
May 2, 2012 |
373 |
| ACT Announces Massachusetts Eye and Ear as Additional Site for Clinical Trial for Dry Age-Related Macular Degeneration Using Human Embryonic Stem Cell-Derived RPE Cells. |
|
|
May 2, 2012 |
1006 |
| Solazyme and Dow Enter into Contingent Global Commercial Offtake Agreement and Concurrently Sign Phase 2 Joint Development Agreement to Accelerate Commercialization of Bio-based Dielectric Insulating Fluids. |
|
|
May 2, 2012 |
1360 |
| Profectus BioSciences Receives NIAID Grant to Develop a Vesicular Stomatitis Virus-vectored Vaccine for Ebola and Marburg Viruses. |
|
|
May 2, 2012 |
904 |
| Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2012 Results. |
|
|
May 2, 2012 |
277 |
| Exelixis Announces May 8th Webcast of Presentation at the Deutsche Bank Securities 37th Annual Health Care Conference. |
|
Conference news |
May 2, 2012 |
269 |
| Roka Bioscience Atlas(TM) System Supports Efficient, Innovative Food Pathogen Testing At QC Laboratories. |
|
|
May 2, 2012 |
533 |
| Sangamo BioSciences Reports First Quarter 2012 Financial Results. |
|
Financial report |
May 2, 2012 |
2883 |
| Institute in Philadelphia to participate in a clinical trial. |
|
|
May 1, 2012 |
190 |
| Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease. |
|
Financial report |
May 1, 2012 |
692 |
| Interleukin Genetics Launches iPhone[R] and iPad[R] App for Its Inherent Health[R] Services. |
|
|
May 1, 2012 |
737 |
| ACADIA Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 8, 2012. |
|
Financial report |
May 1, 2012 |
647 |
| Promedior Announces Presentation of Data at ARVO Demonstrating that Pentraxin-2 Suppresses Fibrosis, Neovascularization, and Vascular Leak in Retinal Disease Models. |
|
|
May 1, 2012 |
515 |
| ZeaChem Names Peter Cheesbrough as Chief Financial Officer. |
|
|
May 1, 2012 |
654 |
| Advaxis Research Accepted for American Association of Immunologists Annual Meeting, Demonstrates Reduction of Tumor Defenses. |
|
|
May 1, 2012 |
787 |
| DARA and Bionectc[R]. |
|
Brief article |
May 1, 2012 |
188 |
| Elemental and effective. |
Corneliussen, Roger |
Brief article |
May 1, 2012 |
199 |
| Vitiva teams up with Naturamed. |
|
|
May 1, 2012 |
102 |
| Vaisala. |
|
|
May 1, 2012 |
264 |
| Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012. |
|
|
May 1, 2012 |
706 |
| Dyadic International Expands License Agreement With Abengoa. |
|
|
May 1, 2012 |
629 |
| THE BIOTECH GROWTH TRUST PLC - Total Voting Rights. |
|
|
May 1, 2012 |
197 |
| Cardio3 BioSciences Granted GMP Certification. |
|
|
May 1, 2012 |
399 |
| Almac Installs Uhlmann Blister Line in New US Commercial Packaging Facility. |
|
|
May 1, 2012 |
471 |
| Spectrum Pharmaceuticals to Present at the Deutsche Bank 37th Annual Health Care Conference. |
|
Conference news |
May 1, 2012 |
660 |
| Compugen Ltd. Reports First Quarter 2012 Financial Results. |
|
Financial report |
May 1, 2012 |
4801 |
| Israel : Pluristem Awarded a $3.1 Million Grant by Israeli Government. |
|
|
Apr 30, 2012 |
396 |
| ANALYST INTERVIEW: Biotech Companies Develop Strong Pipelines & Outperform Indices - Jim Birchenough - BMO Capital Markets Corp. |
|
|
Apr 30, 2012 |
113 |
| ANALYST INTERVIEW: Emerging Midcap Biotech Companies Drive Innovation - Geoffrey Porges - Sanford C. Bernstein & Co., LLC. |
|
|
Apr 30, 2012 |
115 |
| Pharmaceutical Company Merck Serono Signs an Agreement to Use Kadimastem's Platform for Drug Screening. |
|
|
Apr 30, 2012 |
945 |
| PURE Bioscience Partners with Intercon Chemical Company. |
|
|
Apr 30, 2012 |
1365 |
| Personalized Women's Healthcare of Plano Pioneers Breast Cancer Risk Assessment. |
|
|
Apr 30, 2012 |
1316 |
| Aemetis Celebrates One-Year Anniversary of Ethanol Production Facility in Keyes, CA. |
|
|
Apr 30, 2012 |
502 |
| ImmunoReagents Announces Exclusive German Distribution Channel with BioLeague. |
|
|
Apr 29, 2012 |
341 |
| Turkey : Amgen to purchase Mustafa Nevzat Pharmaceuticals. |
|
|
Apr 28, 2012 |
225 |
| Business briefs. |
|
|
Apr 28, 2012 |
435 |
| Elan to Present at Deutsche Bank 37th Annual Healthcare Conference. |
|
Conference news |
Apr 27, 2012 |
175 |
| Tech Council of Maryland Names GlycoMimetics as 2012 Life Sciences Company of the Year. |
|
|
Apr 27, 2012 |
457 |
| BIO Applauds Senate Agriculture Committee for Passing Bipartisan Farm Bill. |
|
|
Apr 27, 2012 |
589 |
| BIO Thanks Reps. Pascrell, Bilbray for Policy that Levels the Playing Field for Renewable Chemicals. |
|
|
Apr 27, 2012 |
582 |
| BUSINESS BRIEFS. |
|
|
Apr 27, 2012 |
272 |
| Research and Markets: Analysis of DuPont. |
|
Company overview |
Apr 26, 2012 |
378 |
| Meridian Bioscience Inc. Added to Premier's Molecular Rapid Qualitative Screening Portfolio. |
|
|
Apr 26, 2012 |
292 |
| ArQule to Report First Quarter 2012 Financial Results on May 3, 2012. |
|
Financial report |
Apr 26, 2012 |
716 |
| Solazyme to Announce First Quarter 2012 Financial Results on May 7, 2012. |
|
Financial report |
Apr 26, 2012 |
516 |
| Advanced Cell Technology Announces Webcast of Corporate Presentation at Annual Shareholders' Meeting Today. |
|
|
Apr 26, 2012 |
572 |
| New National Bioeconomy Blueprint Can Help Unleash the Promise of Biotech to Drive American Innovation, Promote Job Growth and Continue U.S. Competitiveness. |
|
|
Apr 26, 2012 |
595 |
| Alnylam to Webcast Conference Call Discussing First Quarter 2012 Financial Results. |
|
|
Apr 26, 2012 |
544 |
| BIO Asks House Committee on Ways and Means to Extend Critical Tax Provisions. |
|
|
Apr 26, 2012 |
438 |
| Joint Venture Opportunities; PITTSBURGH LIFE SCIENCES GREENHOUSE. |
|
|
Apr 26, 2012 |
105 |
| Joint Venture Opportunities; MASSACHUSETTS BIOMEDICAL INITIATIVES. |
|
|
Apr 26, 2012 |
107 |
| Senator Hagan Honored as BIO Legislator of the Year. |
|
|
Apr 25, 2012 |
395 |
| Senator Enzi Honored as BIO Legislator of the Year. |
|
|
Apr 25, 2012 |
363 |
| Representative Schwartz Honored as BIO Legislator of the Year. |
|
|
Apr 25, 2012 |
405 |
| Representative Rogers Honored as BIO Legislator of the Year. |
|
|
Apr 25, 2012 |
376 |
| Representative Kingston Honored as BIO Legislator of the Year. |
|
|
Apr 25, 2012 |
398 |
| Senator Bob Menendez Honored as BIO Legislator of the Year. |
|
|
Apr 25, 2012 |
368 |
| RBCC: Link Between Parkinson's and Alzheimer's Could Greatly Increase Market for New Therapies. |
|
|
Apr 25, 2012 |
551 |
| Illumina Introduces BaseSpace Apps, Solutions for Genome Informatics. |
|
|
Apr 25, 2012 |
691 |
| Online Business Applications Releases Web-Based IRMS-CE. |
|
|
Apr 25, 2012 |
565 |
| Advaxis to Speak at 2012 World Immunotherapy Online Symposium. |
|
|
Apr 25, 2012 |
599 |
| Groups Ask Senators to Authorize DOE Funding for Interagency Project on Military Biofuel. |
|
|
Apr 25, 2012 |
490 |
| BUSINESS BRIEFS. |
|
|
Apr 25, 2012 |
814 |
| Illumina Launches MyGenome[R] App for iPad[R]. |
|
|
Apr 24, 2012 |
797 |
| Compugen Announces Initial Validation Results for Two Novel Immunomodulatory Proteins and Further Results for CGEN-15001. |
|
Financial report |
Apr 24, 2012 |
1371 |
| Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2012 Financial Results on May 8, 2012. |
|
|
Apr 24, 2012 |
333 |
| PURE Bioscience Announces Positive Research from University of Arkansas. |
|
|
Apr 24, 2012 |
740 |
| Acucela to Present Multiple Posters at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting. |
|
|
Apr 24, 2012 |
628 |
| ACT Announces Data and Safety Monitoring Board (DSMB) Approval to Increase RPE Dosage for Stargardt's Disease Patients in U.S. Trial. |
|
|
Apr 24, 2012 |
1072 |
| Pathway Genomics Adds Prominent Bioinformatics Experts to Scientific Advisory Board. |
|
|
Apr 24, 2012 |
584 |
| Research and Markets: Global Life Sciences Tools and Services Market 2011-2015. |
|
|
Apr 24, 2012 |
406 |
| Significant Improvement in Disability Scores Observed in Multiple Sclerosis Patients Who Received LemtradaTM* (Alemtuzumab) Compared With Rebif[R] in Phase III Trial. |
|
|
Apr 24, 2012 |
2977 |
| Human Genome Sciences Announces First Quarter 2012 Financial Results. |
|
Financial report |
Apr 24, 2012 |
4402 |
| Spectrum Pharmaceuticals Expands Manufacturing Capacity and Builds Inventory Reserves for FUSILEV[R]. |
|
|
Apr 23, 2012 |
1265 |
| Compugen First Quarter 2012 Conference Call Scheduled for Tuesday, May 1, 2012 at 10:00 AM EST. |
|
|
Apr 23, 2012 |
606 |
| ProteoTech's Chief Scientific Officer, Dr. Alan Snow, to Present New Data on "SystebrylTM for the Treatment of Systemic AA Amyloidosis" at the XIIIth International Symposium on Amyloidosis, Groningen, Netherlands, May 6-10, 2012. |
|
|
Apr 23, 2012 |
367 |
| Alnylam Elects Dr. Dennis Ausiello to its Board of Directors and Scientific Advisory Board. |
|
|
Apr 23, 2012 |
1232 |
| Kolltan Pharmaceuticals Appoints Gerald McMahon, Ph.D., President & Chief Executive Officer. |
|
|
Apr 23, 2012 |
898 |
| Retinalyze, LLC Begins Enrolling Ophthalmology Practices. |
|
|
Apr 23, 2012 |
805 |
| Dr. Mary Haak-Frendscho, Chairperson of Compugen's US Subsidiary, to Give Keynote Address at China Pharmaceutical R&D Summit. |
|
|
Apr 23, 2012 |
601 |
| SD Biotech Association Expands Event for Researchers. |
|
|
Apr 23, 2012 |
491 |
| BioTime's Subsidiary LifeMap Sciences, Inc. Presents Update on Product Development. |
|
|
Apr 23, 2012 |
1376 |
| Illumina Reports Financial Results for First Quarter of Fiscal Year 2012. |
|
Financial report |
Apr 23, 2012 |
13126 |
